Directori de persones
Anna Carnes Vendrell

Anna Carnes Vendrell

Grau: Doctor/a

973 727222 (1585)
acarnes(ELIMINAR)@gss.cat

Publicacions

  • Carnes-Vendrell A; Piñol-Ripoll G; Ariza M; Cano N; Segura B; Junque C; Béjar J; Barrue C; Garolera M

    Poor sleep quality may trigger cognitive deficits after recovery from COVID-19.

    Frontiers in Psychology 15 1382875-1382875. .

    [doi:10.3389/fpsyg.2024.1382875]

  • Dakterzada, F; Jové, M; Huerto, R; Carnes, A; Sol, J; Pamplona, R; Piñol-Ripoll, G

    Cerebrospinal fluid neutral lipids predict progression from mild cognitive impairment to Alzheimer's disease

    Geroscience 46 683-696. .

    [doi:10.1007/s11357-023-00989-x]

  • Carnes-Vendrell, A; Piñol-Ripoll, G; Ariza, M; Cano, N; Segura, B; Junque, C; Béjar, J; Barrue, C; Garolera, M

    Sleep quality in individuals with post-COVID-19 condition: Relation with emotional, cognitive and functional variables

    Brain Behavior & Immunity-Health 35 100721-100721. .

    [doi:10.1016/j.bbih.2023.100721]

  • Chino B; Torres-Simón L; Zelwetro A; Rodríguez-Rojo IC; Carnes-Vendrell A; Piñol-Ripoll G; Yubero R; Paúl N; Maestú F

    Understanding the Episodic Memory and Executive Functioning Axis Impairment in MCI Patients: A Multicenter Study in Comparison with CSF Biomarkers.

    Biomedicines 11 -. .

    [doi:10.3390/biomedicines11123147]

  • Guillén, N; Contador, J; Buongiorno, M; Alvarez, I; Culell, N; Alcolea, D; Lleó, A; Fortea, J; Piñol-Ripoll, G; Carnes-Vendrell, A; Ispierto, ML; Vilas, D; Puig-Pijoan, A; Fernández-Lebrero, A; Balasa, M; Sánchez-Valle, R; Lladó, A

    Agreement of cerebrospinal fluid biomarkers and amyloid-PET in a multicenter study

    EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE -. .

    [doi:10.1007/s00406-023-01701-y]

  • Dakterzada, F; Benitez, ID; Targa, A; Carnes, A; Pujol, M; Jove, M; Minguez, O; Vaca, R; Sanchez-de-la-Torre, M; Barbe, F; Pamplona, R; Pinol-Ripoll, G

    Cerebrospinal fluid lipidomic fingerprint of obstructive sleep apnoea in Alzheimer's disease

    Alzheimers Research & Therapy 15 134-134. .

    [doi:10.1186/s13195-023-01278-7]

  • Carnes-Vendrell, A; Barallat-Gimeno, E; Lara, B; Lladó, A; Escobar-Bravo, MA; Reivan-Ortiz, GG; Maxi-Maxi, EA; Martínez-Suárez, PC; Ramírez-Coronel, AA; Piñol-Ripoll, G

    Spanish-Dementia Knowledge Assessment Scale (DKAS-S): Ecuadorian validation and comparison among Spanish health students

    BMC Geriatrics 23 210-210. .

    [doi:10.1186/s12877-023-03904-3]

  • Dakterzada, F; Jove, M; Huerto, R; Carnes, A; Sol, J; Pamplona, R; Piñol-Ripoll G

    Changes in Plasma Neutral and Ether-Linked Lipids Are Associated with The Pathology and Progression of Alzheimer's Disease.

    Aging and Disease 14 1728-1738. .

    [doi:10.14336/AD.2023.0221]

  • Dakterzada, Farida; Benitez, Ivan D.; Targa, Adriano; Carnes, Anna; Pujol, Montse; Jove, Mariona; Minguez, Olga; Vaca, Rafi; Sanchez-de-la-Torre, Manuel; Barbe, Ferran; Pamplona, Reinald; Piñol-Ripoll G

    Blood-based lipidomic signature of severe obstructive sleep apnoea in Alzheimer's disease.

    Alzheimers Research & Therapy 14 163-163. .

    [doi:10.1186/s13195-022-01102-8]

  • Vazquez-Justes, D; Aguirregoicoa, I; Fernandez, L; Carnes-Vendrell, A; Dakterzada, F; Sanjuan, L; Mena, A; Piñol-Ripoll G

    Clinical impact of microbleeds in patients with Alzheimer's disease.

    BMC Geriatrics 22 774-774. .

    [doi:10.1186/s12877-022-03456-y]

  • Targa ADS; Benítez ID; Dakterzada F; Carnes A; Pujol M; Jorge C; Minguez O; Dalmases M; Sánchez-de-la-Torre M; Barbé F; Piñol-Ripoll G

    Sleep profile predicts the cognitive decline of mild-moderate Alzheimer's disease patients.

    Sleep 44 -. .

    [doi:10.1093/sleep/zsab117]

  • Carnes A; Barallat-Gimeno E; Galvan A; Lara B; Lladó A; Contador-Muñana J; Vega-Rodriguez A; Escobar MA; Piñol-Ripoll G

    Spanish-dementia knowledge assessment scale (DKAS-S): psychometric properties and validation.

    BMC Geriatrics 21 302-302. .

    [doi:10.1186/s12877-021-02230-w]

Projectes

  • Importancia del sueño y los ritmos circadianos en la biología y evolución clínica de los sujetos en el continuum de la Enfermedad de Alzheimer.
  • PMP-DEGESCO: Validación de una herramienta de medicina de precisión basada en evaluación cognitiva online, estratificación del riesgo genético y biomarcadores sanguíneos para la identificación de la Enfermedad de Alzheimer preclínica (Proyecto SCAP-AD)